Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives First Global Shipment of Psilocybin from Company'

  • Groundbreaking and major precedent setting milestone as first global shipment, via USA Controlled Substances import permit, of naturally occurring Psilocybin from Red Light Holland's facility in Europe successfully delivered to the Company's Partner FDA-Compliant and DEA-Registered Irvine Labs in California Psilocybin potency testing and implementation of advanced shelf life extension protocols are immediately underway Red Light Holland and Irvine Labs combined goal is to develop a commercialized and standardized psilocybin product that can be legally sold to emerging markets and used in government-funded pilot programs and clinical trials within the United States Toronto, Ontario--(Newsfile Corp. - July 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has successfully shipped the Company's naturally occurring psilocybin from their facility in the Netherlands to their research and development partner, Irvine Labs Inc. ("Irvine Labs"), an FDA-compliant and DEA-registered facility in California, United States. With the DEA quota secured and United States Controlled Substances import permit approved, Irvine Labs has now successfully received Red Light Holland's natural psilocybin products, grown in the company's facility in the Netherlands.